81 World Health Organization who technical Report Series, No. 957, 2010


Selection of the specifi cations to be used



Download 176.21 Kb.
View original pdf
Page29/44
Date13.07.2021
Size176.21 Kb.
#57067
1   ...   25   26   27   28   29   30   31   32   ...   44
pharmaceutical analysis

Selection of the specifi cations to be used
15.9 The specifi cation necessary to assess the sample maybe that given in the test request or master production instructions. If no precise instruction is given, the specifi cation in the of cially recognized national pharmacopoeia maybe used or, failing this, the manufacturer’s of cially approved or other nationally recognized specifi cation. If no suitable method is available:
(a) the specifi cation contained in the marketing authorization or product licence maybe requested from the marketing authorization holder or manufacturer and verifi ed by the laboratory orb) the requirements maybe set by the laboratory itself on the basis of published information and any procedure employed is to be validated by the testing laboratory (see Part three, section 16).
15.10 For of cial specifi cations the current version of the relevant pharmacopoeia should be available.
Filing
15.11 The analytical worksheet should be kept safely together with any attachments, including calculations and recordings of instrumental analyses.
16.

Download 176.21 Kb.

Share with your friends:
1   ...   25   26   27   28   29   30   31   32   ...   44




The database is protected by copyright ©ininet.org 2024
send message

    Main page